Multidisciplinary Treatment for Advanced Invasive Thymoma with Cisplatin, Doxorubicin, and Methylprednisolone
- 1 January 2007
- journal article
- research article
- Published by Elsevier BV in Journal of Thoracic Oncology
- Vol. 2 (1), 73-78
- https://doi.org/10.1097/jto.0b013e31802bafc8
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Long-term survival and prognostic factors in thymic epithelial tumours☆European Journal of Cardio-Thoracic Surgery, 2004
- Treatment of Invasive Thymoma With Single-Agent IfosfamideJournal of Clinical Oncology, 1999
- Results of surgical treatment of thymomas with special reference to the involved organsThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Multimodality Treatment of Thymoma: A Prospective StudyThe Annals of Thoracic Surgery, 1997
- Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial.Journal of Clinical Oncology, 1997
- Prognostic factors and long-term results after thymoma resection: A series of 307 patientsThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.Journal of Clinical Oncology, 1996
- Thymoma: A multivariate analysis of factors predicting survivalThe Annals of Thoracic Surgery, 1995
- Treatment of invasive thymoma with pleural disseminationJournal of Surgical Oncology, 1993
- Chemotherapy for invasive thymoma. A 13-year experienceCancer, 1991